Perrigo (PRGO) Change in Inventory (2013 - 2026)
Perrigo (PRGO) posted quarterly Change in Inventory of -$23.6 million for Q1 2026, down 137.76% year-over-year from $62.5 million in Q1 2025, and up 71.43% quarter-over-quarter from -$82.6 million in Q4 2025.
Perrigo (PRGO) Change in Inventory (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Change in Inventory for 14 consecutive years, with -$23.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 137.76% year-over-year to -$23.6 million; the TTM figure through Mar 2026 stood at -$25.0 million (down 142.09% YoY), while the FY2025 annual figure was $61.1 million, up 545.99% from the prior year.
- Change in Inventory climbed to -$23.6 million in Q1 2026 per PRGO's latest filing, from -$82.6 million in the prior quarter.
- Across five years, Change in Inventory topped out at $62.5 million in Q1 2025 and bottomed at -$82.6 million in Q4 2025.
- Historically, Change in Inventory has averaged $1.9 million across 5 years, with a median of $6.4 million in 2022.
- Annual changes were most pronounced in 2023 — Change in Inventory tumbled 1085.71% — and 2025, when it soared 689.62%.
- Perrigo's Change in Inventory stood at -$2.1 million in 2022, then sank by 1085.71% to -$24.9 million in 2023, then fell by 14.06% to -$28.4 million in 2024, then plunged by 190.85% to -$82.6 million in 2025, then soared by 71.43% to -$23.6 million in 2026.
- Business Quant data shows PRGO's Change in Inventory at -$23.6 million in Q1 2026, -$82.6 million in Q4 2025, and $46.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | -50.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -50.60 Mn |
| Jun 27, 2026 | -50.60 Mn |
| Mar 28, 2026 | -23.60 Mn |
| Mar 28, 2026 | -23.60 Mn |
| Dec 31, 2025 | -82.60 Mn |
| Dec 31, 2025 | -82.60 Mn |
| Sep 27, 2025 | 46.30 Mn |
| Sep 27, 2025 | 46.30 Mn |
| Jun 28, 2025 | 34.90 Mn |
| Jun 28, 2025 | 34.90 Mn |
| Mar 29, 2025 | 62.50 Mn |
| Mar 29, 2025 | 62.50 Mn |
| Dec 31, 2024 | -28.40 Mn |
| Dec 31, 2024 | -28.40 Mn |
| Sep 28, 2024 | 11.80 Mn |
| Sep 28, 2024 | 11.80 Mn |
| Jun 29, 2024 | 13.50 Mn |
| Jun 29, 2024 | 13.50 Mn |
| Mar 30, 2024 | -10.60 Mn |
| Mar 30, 2024 | -10.60 Mn |